CELLINK has received a grant to develop a new organ-like in vitro model that can be used in drug development and testing for renal diseases.
CELLINK today announced that it has received funding from Vinnova for a project in collaboration with ibidi GmbH and NMI (Naturwissenschaftliches und Medizinisches Institut). The project will start in August this year and is expected to run until 2023. CELLINK will receive a grant of approximately two million SEK during the course of the project from Vinnova, a government agency in Sweden that administers state funding for innovative research and development. The project aims to develop a new organ-like in vitro model of the proximal tubule in a microfluidic perfusable device in